With a transmission rate greater than SARS or the common flu, COVID-19 quickly spread across the globe, requiring unprecedented efforts to limit its impact and propagation. At the heart of this ongoing battle, data science is playing a game-changing role.
In December 2019, the first outbreak of COVID-19 was detected in China, later spreading to every continent except Antarctica. Data science, along with statistical analysis, computer science, and computational biology, is driving applications from epidemiology to drug discovery and molecular design for therapeutic purposes. Data-driven, mathematical, and predictive models are providing insights into the spread of COVID-19, who is most at risk, and how to live with an endemic virus.
“I think the biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning.”
Predicting COVID-19 Trends and Hotspots
Determining where the next surge in coronavirus cases could happen is critical for governments and public health practitioners. For example, to get a real-time picture of how the virus is moving around the world, Johnson & Johnson built a global surveillance dashboard. Pulling in data at a country, state, and county level guided where they tested their investigational COVID-19 vaccine candidate.
Data also helps identify those most at risk, including what might make someone more prone to severe illness and how different treatment courses may affect patient outcomes. For example, machine learning has enabled us to accurately categorize, or predict, who is likely to be immune from COVID-19 and who is in the 20% at-risk group. Those predictions allowed health authorities to focus their efforts and increase the efficacy of public health interventions and policies.
Life Beyond the Pandemic
As many countries attempt to “learn to live with COVID-19” and get back on track, key decisions need to be made. These include when to return to the workplace. Data science enables companies to decide how many people can be on-site at a time and how facilities should be configured and sanitized.
March 11, 2020: The Pandemic.
COVID-19 is declared a pandemic by the World Health Organization (WHO).
March 18, 2020: The Solidarity Trial
WHO and partners launch the Solidarity Trial, an international clinical trial to generate robust data to find the most effective treatments for COVID-19.
December 2020: Pfizer-BioNTech Vaccine is Approved
Input from advanced datasets and models enable the development and delivery of the first Pfizer-BioNTech COVID-19 vaccines in the U.S.